IL22 and metabolic dysfunction-associated steatotic liver disease: The protective roles of ILC3s in NAFLD are majorly mediated by IL-22 stimulated by IL-23, which contributes to the upregulation of hepatic lipid metabolism and inhibition of palmitate-induced apoptosis of hepatocytes [35].